Biotin-Acridine Red Cell Exchange Kinetics

Clinical trial NCT07155031 · WITHDRAWN

Trial details

NCT number: NCT07155031
Sponsor: Cerus Corporation
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2025-10-15
Primary completion: 2026-09-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.